CoChat

Mini-review: amyloid degradation toxicity hypothesis of Alzheimer's disease

Zaretsky, Dmitry V., Zaretskaia, Maria V. · 2021 · Neuroscience Letters
Cited by 28

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neulet.2021.135959

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 95

  1. Akgoc, 2015, Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses, J. Lipid Res., 56, 1006, 10.1194/jlr.M057851 · DOI
  2. Alarcon, 2006, Ion channel formation by Alzheimer’s disease amyloid beta-peptide (Abeta40) in unilamellar liposomes is determined by anionic phospholipids, Peptides, 27, 95, 10.1016/j.peptides.2005.07.004 · DOI
  3. Arbor, 2016, Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores, Yale J. Biol. Med., 89, 5
  4. Arispe, 2007, Aβ ion channels. Prospects for treating Alzheimer’s disease with Aβ channel blockers, Biochimica et Biophysica Acta (BBA) - Biomembranes, 1768, 1952, 10.1016/j.bbamem.2007.03.014 · DOI · Paper page
  5. Arispe, 1994, The ability of amyloid beta-protein [A beta P (1-40)] to form Ca2+ channels provides a mechanism for neuronal death in Alzheimer’s disease, Ann. N. Y. Acad. Sci., 747, 256, 10.1111/j.1749-6632.1994.tb44414.x · DOI
  6. Arispe, 1994, Beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease, Mol. Cell. Biochem., 140, 119, 10.1007/BF00926750 · DOI · Paper page
  7. Arispe, 1993, Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes, Proc. Natl. Acad. Sci. U. S. A., 90, 10573, 10.1073/pnas.90.22.10573 · DOI · Paper page
  8. Arispe, 1996, Zn2+ interaction with Alzheimer amyloid beta protein calcium channels, Proc. Natl. Acad. Sci., 93, 1710, 10.1073/pnas.93.4.1710 · DOI · Paper page
  9. Arispe, 1993, Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum, Proc. Natl. Acad. Sci. U. S. A., 90, 567, 10.1073/pnas.90.2.567 · DOI · Paper page
  10. Audano, 2018, Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration, J. Neurochem., 147, 291, 10.1111/jnc.14471 · DOI
  11. Bevers, 2016, Getting to the outer leaflet: physiology of phosphatidylserine exposure at the plasma membrane, Physiol. Rev., 96, 605, 10.1152/physrev.00020.2015 · DOI · Paper page
  12. Blass, 2000, The mitochondrial spiral. An adequate cause of dementia in the Alzheimer’s syndrome, Ann. N. Y. Acad. Sci., 924, 170, 10.1111/j.1749-6632.2000.tb05576.x · DOI
  13. Bode, 2017, Ion channel formation by Amyloid-β42 oligomers but not Amyloid-β40 in cellular membranes, J. Biol. Chem., 292, 1404, 10.1074/jbc.M116.762526 · DOI · Paper page
  14. Busche, 2016, Impairments of neural circuit function in Alzheimer’s disease, Philosophical transactions of the Royal Society of London, Series B, Biological sciences, 371
  15. Camara, 2017, Mitochondrial VDAC1: a key gatekeeper as potential therapeutic target, Front. Physiol., 8, 10.3389/fphys.2017.00460 · DOI · Paper page
  16. Cascella, 2017, Soluble oligomers require a ganglioside to trigger neuronal calcium overload, J. Alzheimer’s Dis.: JAD, 60, 923, 10.3233/JAD-170340 · DOI
  17. Cavallo-Medved, 2011, Cathepsin B: basis sequence: mouse, AFCS Nat. Mol. Pages, 2011
  18. Cenini, 2019, Mitochondria as potential targets in Alzheimer disease therapy: an update, Front. Pharmacol., 10, 902, 10.3389/fphar.2019.00902 · DOI · Paper page
  19. Cha, 2012, Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death, PLoS One, 7, e34929, 10.1371/journal.pone.0034929 · DOI · Paper page
  20. Chakravorty, 2019, Dysfunctional mitochondria and mitophagy as drivers of Alzheimer’s disease pathogenesis, Front. Aging Neurosci., 11, 311, 10.3389/fnagi.2019.00311 · DOI · Paper page
  21. Chen, 2007, Amyloid-beta-induced mitochondrial dysfunction, J. Alzheimer’s Dis.: JAD, 12, 177, 10.3233/JAD-2007-12208 · DOI · Paper page
  22. Chen, 2010, Role of mitochondrial amyloid-beta in Alzheimer’s disease, J. Alzheimer’s Dis.: JAD, 20, S569, 10.3233/JAD-2010-100357 · DOI · Paper page
  23. Cherra, 2008, Autophagy in neuroprotection and neurodegeneration: a question of balance, Future Neurol., 3, 309, 10.2217/14796708.3.3.309 · DOI · Paper page
  24. Colombini, 2012, VDAC structure, selectivity, and dynamics, Biochim. Biophys. Acta, 1818, 1457, 10.1016/j.bbamem.2011.12.026 · DOI · Paper page
  25. Comte, 1976, Lipid composition and protein profiles of outer and inner membranes from pig heart mitochondria. Comparison with microsomes, Biochimica et biophysica acta, 419, 271, 10.1016/0005-2736(76)90353-9 · DOI · Paper page
  26. de Leon, 2007, Imaging and CSF studies in the preclinical diagnosis of Alzheimer’s disease, Ann. N. Y. Acad. Sci., 1097, 114, 10.1196/annals.1379.012 · DOI · Paper page
  27. Demetrius, 2015, Alzheimer’s disease: the amyloid hypothesis and the Inverse Warburg effect, Front. Physiol., 5, 522, 10.3389/fphys.2014.00522 · DOI
  28. Diaz, 2009, Small molecule blockers of the Alzheimer Abeta calcium channel potently protect neurons from Abeta cytotoxicity, Proc. Natl. Acad. Sci. U. S. A., 106, 3348, 10.1073/pnas.0813355106 · DOI
  29. Drews, 2016, Individual aggregates of amyloid beta induce temporary calcium influx through the cell membrane of neuronal cells, Sci. Rep., 6, 31910, 10.1038/srep31910 · DOI
  30. Durell, 1994, Theoretical models of the ion channel structure of amyloid beta-protein, Biophys. J., 67, 2137, 10.1016/S0006-3495(94)80717-9 · DOI · Paper page
  31. Evangelisti, 2013, Lipid rafts mediate amyloid-induced calcium dyshomeostasis and oxidative stress in Alzheimer’s disease, Curr. Alzheimer Res., 10, 143, 10.2174/1567205011310020004 · DOI
  32. Fan, 2020, New insights into the pathogenesis of Alzheimer’s disease, Front. Neurol., 10, 10.3389/fneur.2019.01312 · DOI · Paper page
  33. Frautschy, 1996, Rodent models of Alzheimer’s disease: rat aβ infusion approaches to amyloid deposits, Neurobiol. Aging, 17, 311, 10.1016/0197-4580(95)02073-X · DOI
  34. Fukunaga, 2012, GM1 cluster mediates formation of toxic Abeta fibrils by providing hydrophobic environments, Biochemistry, 51, 8125, 10.1021/bi300839u · DOI
  35. Green, 2011, SnapShot: mitochondrial quality control, Cell, 147, 950, 10.1016/j.cell.2011.10.036 · DOI
  36. Guicciardi, 2004, Lysosomes in cell death, Oncogene, 23, 2881, 10.1038/sj.onc.1207512 · DOI · Paper page
  37. Hirakura, 1999, Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red, J. Neurosci. Res., 57, 458, 10.1002/(SICI)1097-4547(19990815)57:4<458::AID-JNR5>3.0.CO;2-4 · DOI
  38. Hsu, 2009, A novel defense mechanism that is activated on amyloid-β insult to mediate cell survival: role of SGK1-STAT1/STAT2 signaling, Cell Death Differ., 16, 1515, 10.1038/cdd.2009.91 · DOI
  39. Ikeda, 2011, Mechanism of amyloid beta-protein aggregation mediated by GM1 ganglioside clusters, Biochemistry, 50, 6433, 10.1021/bi200771m · DOI · Paper page
  40. Jakoš, 2019, Cysteine cathepsins in tumor-associated immune cells, Front. Immunol., 10, 10.3389/fimmu.2019.02037 · DOI
  41. Jang, 2010, Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer’s Disease and Down syndrome, Proc. Natl. Acad. Sci. U. S. A., 107, 6538, 10.1073/pnas.0914251107 · DOI · Paper page
  42. Jang, 2013, Alzheimer’s disease: which type of amyloid-preventing drug agents to employ?, Phys. Chem. Chem. Phys.: PCCP, 15, 8868, 10.1039/c3cp00017f · DOI
  43. Jean, 2015, Stereotaxic infusion of oligomeric amyloid-beta into the mouse Hippocampus, J. visualized Exp.: JoVE, 10.3791/52805 · DOI
  44. Kagan, 2002, The channel hypothesis of Alzheimer’s disease: current status, Peptides, 23, 1311, 10.1016/S0196-9781(02)00067-0 · DOI · Paper page
  45. Kavčič, 2017, Lysosomes in programmed cell death pathways: from initiators to amplifiers %, J. Biol. Chem., 398, 289, 10.1515/hsz-2016-0252 · DOI · Paper page
  46. Kawarabayashi, 2004, Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer’s disease, J. Neurosci., 24, 3801, 10.1523/JNEUROSCI.5543-03.2004 · DOI · Paper page
  47. Kayed, 2013, Molecular mechanisms of amyloid oligomers toxicity, J. Alzheimer’s Dis.: JAD, 33, S67
  48. Leventis, 2010, The distribution and function of phosphatidylserine in cellular membranes, Annu. Rev. Biophys., 39, 407, 10.1146/annurev.biophys.093008.131234 · DOI · Paper page
  49. Lin, 2017, Lipid rafts sense and direct electric field-induced migration, Proc. Natl. Acad. Sci. U. S. A., 114, 8568, 10.1073/pnas.1702526114 · DOI
  50. Lin, 2015, Single-cell screening of cytosolic [Ca(2+)] reveals cell-selective action by the Alzheimer’s Aβ peptide ion channel, Cell Stress Chaperones, 20, 333, 10.1007/s12192-014-0551-2 · DOI
  51. Lin, 2001, Amyloid beta protein forms ion channels: implications for Alzheimer’s disease pathophysiology, FASEB J.: Off. Pub. Fed. Am. Soc. Exp. Biol., 15, 2433, 10.1096/fj.01-0377com · DOI · Paper page
  52. Lin, 1999, Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles, Biochemistry, 38, 11189, 10.1021/bi982997c · DOI · Paper page
  53. Lin, 2002, Electrophysiologic properties of channels induced by Abeta25-35 in planar lipid bilayers, Peptides, 23, 1215, 10.1016/S0196-9781(02)00057-8 · DOI
  54. Magrì, 2018, VDAC1 as pharmacological target in Cancer and neurodegeneration: focus on its role in apoptosis, Front. Chem., 6, 108, 10.3389/fchem.2018.00108 · DOI · Paper page
  55. Mirzabekov, 1994, Channel formation in planar lipid bilayers by a neurotoxic fragment of the beta-amyloid peptide, Biochem. Biophys. Res. Commun., 202, 1142, 10.1006/bbrc.1994.2047 · DOI
  56. Mosconi, 2007, Early detection of Alzheimer’s disease using neuroimaging, Exp. Gerontol., 42, 129, 10.1016/j.exger.2006.05.016 · DOI · Paper page
  57. Naldi, 2012, Amyloid β-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer’s disease process and treatment, ACS Chem. Neurosci., 3, 952, 10.1021/cn3000982 · DOI
  58. Nixon, 2005, Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study, J. Neuropathol. Exp. Neurol., 64, 113, 10.1093/jnen/64.2.113 · DOI · Paper page
  59. Nixon, 2011, Autophagy failure in Alzheimer’s disease--locating the primary defect, Neurobiol. Dis., 43, 38, 10.1016/j.nbd.2011.01.021 · DOI · Paper page
  60. Okada, 2008, Formation of toxic Abeta(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Abeta(1-40) fibrils, J. Mol. Biol., 382, 1066, 10.1016/j.jmb.2008.07.072 · DOI
  61. Parodi, 2010, Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure, J. Biol. Chem., 285, 2506, 10.1074/jbc.M109.030023 · DOI · Paper page
  62. Pollard, 1995, Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity, Cell. Mol. Neurobiol., 15, 513, 10.1007/BF02071314 · DOI
  63. Pollard, 1993, A new hypothesis for the mechanism of amyloid toxicity, based on the calcium channel activity of amyloid beta protein (A beta P) in phospholipid bilayer membranes, Ann. N. Y. Acad. Sci., 695, 165, 10.1111/j.1749-6632.1993.tb23046.x · DOI
  64. Reddy, 2013, Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer’s disease?, Biochimica et Biophysica Acta (BBA) – Mol. Basis Dis., 1832, 67, 10.1016/j.bbadis.2012.09.003 · DOI
  65. Rhee, 1998, Amyloid beta protein-(1-42) forms calcium-permeable, Zn2+-sensitive channel, J. Biol. Chem., 273, 13379, 10.1074/jbc.273.22.13379 · DOI · Paper page
  66. Samara, 2008, Autophagy is required for necrotic cell death in Caenorhabditis elegans, Cell Death Differ., 15, 105, 10.1038/sj.cdd.4402231 · DOI · Paper page
  67. Schmitt, 2012, Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio, Antioxid. Redox Signal., 16, 1456, 10.1089/ars.2011.4400 · DOI · Paper page
  68. Schubert, 1997, Serpins inhibit the toxicity of amyloid peptides, Eur. J. Neurosci., 9, 770, 10.1111/j.1460-9568.1997.tb01425.x · DOI · Paper page
  69. Sciacca, 2012, Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation, Biophys. J., 103, 702, 10.1016/j.bpj.2012.06.045 · DOI · Paper page
  70. Segawa, 2015, An apoptotic’ Eat Me’ signal: phosphatidylserine exposure, Trends Cell Biol., 25, 639, 10.1016/j.tcb.2015.08.003 · DOI · Paper page
  71. Shirwany, 2007, The amyloid beta ion channel hypothesis of Alzheimer’s disease, Neuropsychiatr. Dis. Treat., 3, 597
  72. Simmons, 1993, Amyloid beta peptides act directly on single neurons, Neurosci. Lett., 150, 133, 10.1016/0304-3940(93)90519-Q · DOI
  73. Smith, 2017, Binding sites for Amyloid-β oligomers and synaptic toxicity, Cold Spring Harb. Perspect. Med., 7, 10.1101/cshperspect.a024075 · DOI · Paper page
  74. Sokolov, 2006, Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure, J. Gen. Physiol., 128, 637, 10.1085/jgp.200609533 · DOI · Paper page
  75. Takuma, 2004, Amyloid Beta peptide-induced cerebral neuronal loss is mediated by Caspase-3 in vivo, J. Neuropathol. Exp. Neurol., 63, 255, 10.1093/jnen/63.3.255 · DOI
  76. Teixeira, 2019, Future therapeutic perspectives into the Alzheimer’s disease targeting the oxidative stress hypothesis, Molecules, 24, 10.3390/molecules24234410 · DOI
  77. Teplow, 2013, On the subject of rigor in the study of amyloid β-protein assembly, Alzheimers Res. Ther., 5, 39, 10.1186/alzrt203 · DOI
  78. Thinnes, 2010, Amyloid Aß, cut from APP by ß-secretase BACE1 and γ-secretase, induces apoptosis via opening type-1 porin/VDAC in cell membranes of hypometabolic cells-A basic model for the induction of apoptosis!?, Mol. Genet. Metab., 101, 301, 10.1016/j.ymgme.2010.07.007 · DOI
  79. Thinnes, 2015, Plasmalemmal VDAC-1 corroborated as amyloid Aß-receptor, Front. Aging Neurosci., 7, 188, 10.3389/fnagi.2015.00188 · DOI
  80. Todkar, 2019, Mitochondrial interaction with the endosomal compartment in endocytosis and mitochondrial transfer, Mitochondrion, 49, 284, 10.1016/j.mito.2019.05.003 · DOI
  81. Turk, 1995, Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins, Biol. Chem. Hoppe-Seyler, 376, 225, 10.1515/bchm3.1995.376.4.225 · DOI · Paper page
  82. Turk, 2002, Apoptotic pathways: involvement of lysosomal proteases, Biol. Chem., 383, 1035, 10.1515/BC.2002.112 · DOI · Paper page
  83. Van Dam, 2011, Animal models in the drug discovery pipeline for Alzheimer’s disease, Br. J. Pharmacol., 164, 1285, 10.1111/j.1476-5381.2011.01299.x · DOI · Paper page
  84. Vestergaard, 2010, Cholesterol, lipids, amyloid Beta, and Alzheimer’s, Curr. Alzheimer Res., 7, 262, 10.2174/156720510791050821 · DOI
  85. Whittington, 2017, Impaired resolution of inflammation in Alzheimer’s disease: a review, Front. Immunol., 8, 1464, 10.3389/fimmu.2017.01464 · DOI
  86. Wolfe, 2013, Autophagy failure in Alzheimer’s disease and the role of defective lysosomal acidification, Eur. J. Neurosci., 37, 1949, 10.1111/ejn.12169 · DOI · Paper page
  87. Wong, 2010, Autophagy gone awry in neurodegenerative diseases, Nat. Neurosci., 13, 805, 10.1038/nn.2575 · DOI · Paper page
  88. Wouters, 2016, Cathepsin B pulls the emergency brake on cellular necrosis, Cell Death Dis., 7, e2170, 10.1038/cddis.2016.76 · doi:10.1038/cddis.2016.76
  89. Wu, 2019, Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling, Mitochondrion, 49, 35, 10.1016/j.mito.2019.07.003 · DOI · Paper page
  90. Yang, 1998, Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis, J. Neurosci. Res., 52, 691, 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3 · doi:10.1002/(sici)1097-4547(19980615)52:6<691::aid-jnr8>3.0.co;2-3
  91. Yang, 2007, Induction of autophagy in neurite degeneration of mouse superior cervical ganglion neurons, Eur. J. Neurosci., 26, 2979, 10.1111/j.1460-9568.2007.05914.x · DOI
  92. Yao, 2018, Inhibiting autophagy reduces retinal degeneration caused by protein misfolding, Autophagy, 14, 1226, 10.1080/15548627.2018.1463121 · DOI
  93. Youle, 2011, Mechanisms of mitophagy, Nature reviews, Mol. cell Boil., 12, 9
  94. Zaretsky, 2020, Degradation products of amyloid protein: are they the culprits?, Curr. Alzheimer Res., 17, 869, 10.2174/1567205017666201203142103 · DOI
  95. Zaretsky, 2020, Flow cytometry method to quantify the formation of beta-amyloid membrane ion channels, Biochimica et biophysica acta. Biomembranes

Metadata

Authors
Zaretsky, D. V., & Zaretskaia, M. V.
Venue
Neuroscience Letters
Publisher
Elsevier BV
Published
2021-06
Volume
756
Pages
135959
ISSN
0304-3940
Cited by
28
References
16
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mini-review: amyloid degradation toxicity hypothesis of Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neulet.2021.135959
The paper
Zaretsky, D. V., & Zaretskaia, M. V. (2021). Mini-review: amyloid degradation toxicity hypothesis of Alzheimer's disease. Neuroscience Letters. https://doi.org/10.1016/j.neulet.2021.135959

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.